aspirin has been researched along with Bronchial Hyperreactivity in 33 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study raises further interesting therapeutic possibilities and warrants further trials of new approaches to the treatment of aspirin-intolerant asthma." | 9.09 | Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. ( Amayasu, H; Hasegawa, H; Nakagawa, H; Sakamoto, H; Shoji, T; Yoshida, S, 1999) |
| "We assessed the effects of pretreatment with pranlukast on bronchoconstriction precipitated by inhalation of methacholine and sulpyrine in 16 adult patients with mild or moderate aspirin-intolerant asthma; those who were in stable clinical condition and were hypersensitive to sulpyrine provocation testing were allocated to this study." | 9.09 | Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma. ( Amayasu, H; Hasegawa, H; Ishizaki, Y; Nakabayashi, M; Nakagawa, H; Onuma, K; Sakamoto, H; Shoji, T; Yoshida, S, 2000) |
| "Little is known about the anti-asthmatic effects of powerful anti-inflammatory agents such as aspirin-like drugs." | 9.09 | Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses. ( Bianco, S; Pieroni, MG; Refini, RM; Robuschi, M; Sestini, P; Vaghi, A, 1999) |
| "Inhaled cromolyn sodium protect against aspirin-induced attacks of asthma through mechanisms not related to the bronchodilator property, but related to the improvement of the bronchial hypersensitivity, almost completely in all patients (P < 0." | 9.09 | Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma. ( Akahori, K; Amayasu, H; Hasegawa, H; Ishizaki, Y; Nakabayashi, M; Nakagawa, H; Shoji, T; Yoshida, S, 2001) |
| "From bronchoprovocation studies and investigations of the acute effects of drugs that inhibit leukotrienes (LT), the hypothesis has emerged that leukotrienes are important mediators of airway obstruction and other symptoms in aspirin-intolerant asthma (AIA)." | 9.08 | Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. ( Bochenek, G; Boodhoo, TI; Dahlén, B; Dahlén, SE; Dubé, LM; Kumlin, M; Mastalerz, L; Nizankowska, E; Pinis, G; Swanson, LJ; Szczeklik, A; Wright, S; Zetterström, O, 1998) |
| "This study was designed to investigate the protective effect of cromolyn sodium on airway sensitivity to sulpyrine, and bronchial responsiveness to methacholine, and to investigate whether this protective activity is associated with reduction in aspirin-induced excretion of urinary leukotriene E4 (u-LTE4), a marker of the cysteinyl LT overproduction that participates in the pathogenesis of aspirin-induced asthma." | 9.08 | Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma. ( Akahori, K; Amayasu, H; Hasegawa, H; Nakabayashi, M; Nakagawa, H; Sakamoto, H; Sakamoto, M; Shoji, T; Tajimab, T; Yamawaki, Y; Yoshida, S, 1998) |
| " To investigate whether prostaglandin production could also modulate the bronchial antireactive activity of this diuretic drug, we investigated the effect of inhaled lysine acetylsalicylate (162 mg) and of furosemide (18 mg), alone and in combination, on the bronchial obstructive response to ultrasonically nebulized water in asthmatic patients." | 9.07 | Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate. ( Berni, F; Bianco, S; Pieroni, MG; Refini, RM; Robuschi, M; Sestini, P; Vaghi, A, 1993) |
| " The coexistence of CRS, bronchial asthma and aspirin intolerance (aspirin triad) is an adverse prognostic factor with higher risk of recurrences." | 7.91 | Analysis of the impact of bronchial asthma and hypersensitivity to aspirin on the clinical course of chronic sinusitis with nasal polyps. ( Dąbrowska, K; Fendler, W; Pagacz, K; Pietruszewska, W; Podwysocka, M, 2019) |
| "A considerable number of asthmatic patients with no history of aspirin intolerance responded to the inhalation aspirin challenge." | 7.76 | Airway responsiveness to inhaled aspirin is influenced by airway hyperresponsiveness in asthmatic patients. ( Choi, IS; Han, ER; Kim, CS; Kim, DE; Kim, S; Kim, YJ; Park, DJ, 2010) |
| "Cysteinyl leukotrienes (cysLTs) are considered to be the most important mediator involved in the pathogenesis of aspirin-intolerant asthma (AIA)." | 7.70 | Effects of pranlukast, a cysteinyl leukotriene antagonist, on bronchial responsiveness to methacholine in aspirin-intolerant asthmatics treated with corticosteroids. ( Haruta, Y; Hiyama, K; Hozawa, S; Ishioka, S; Maeda, A; Tamagawa, K; Watanabe, T; Yamakido, M, 2000) |
| "Sensitivity to amalgam may cause exacerbation of aspirin-intolerant asthma in some patients." | 7.70 | Amalgam allergy associated with exacerbation of aspirin-intolerant asthma. ( Amayasu, H; Hasegawa, H; Ishizaki, Y; Mikami, H; Nakagawa, H; Onuma, K; Shoji, T; Yoshida, S, 1999) |
| "Inhalation of aerosolized lysine-aspirin (L-ASA) has been described as an alternative diagnostic method in aspirin-sensitive asthma." | 7.69 | Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. ( Park, HS, 1995) |
| " In aspirin asthma following aspirin bronchial provocation NCA increases in 50% to 100% of the studied patients." | 7.68 | [Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity]. ( Grzegorczyk, J; Grzelewska-Rzymowska, I; Rozniecki, J; Szmidt, M, 1991) |
| " We assayed urinary LTE4 in 17 normal subjects, 31 subjects with asthma without aspirin sensitivity, and 10 aspirin-sensitive subjects." | 7.68 | Urinary leukotriene E4 in bronchial asthma. ( Christie, PE; Hawksworth, RJ; Lee, TH; Smith, CM; Thien, FC, 1992) |
| "The inhalation challenge with lysine-aspirin (L-ASA) using the dosimeter method allows the construction of a dose-response curve and the quantitative estimation of airway responsiveness to the drug." | 5.28 | Aspirin-induced asthma and bronchial hyperresponsiveness. ( Cocco, G; Masi, C; Melillo, E; Melillo, G; Padovano, A, 1991) |
| " This study raises further interesting therapeutic possibilities and warrants further trials of new approaches to the treatment of aspirin-intolerant asthma." | 5.09 | Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. ( Amayasu, H; Hasegawa, H; Nakagawa, H; Sakamoto, H; Shoji, T; Yoshida, S, 1999) |
| "We assessed the effects of pretreatment with pranlukast on bronchoconstriction precipitated by inhalation of methacholine and sulpyrine in 16 adult patients with mild or moderate aspirin-intolerant asthma; those who were in stable clinical condition and were hypersensitive to sulpyrine provocation testing were allocated to this study." | 5.09 | Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma. ( Amayasu, H; Hasegawa, H; Ishizaki, Y; Nakabayashi, M; Nakagawa, H; Onuma, K; Sakamoto, H; Shoji, T; Yoshida, S, 2000) |
| "Little is known about the anti-asthmatic effects of powerful anti-inflammatory agents such as aspirin-like drugs." | 5.09 | Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses. ( Bianco, S; Pieroni, MG; Refini, RM; Robuschi, M; Sestini, P; Vaghi, A, 1999) |
| "Inhaled cromolyn sodium protect against aspirin-induced attacks of asthma through mechanisms not related to the bronchodilator property, but related to the improvement of the bronchial hypersensitivity, almost completely in all patients (P < 0." | 5.09 | Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma. ( Akahori, K; Amayasu, H; Hasegawa, H; Ishizaki, Y; Nakabayashi, M; Nakagawa, H; Shoji, T; Yoshida, S, 2001) |
| " In study 1, 15 non-aspirin sensitive patients with mild asthma attended on four occasions and inhaled 5 ml of lysine aspirin (L-aspirin) 900 mg, indomethacin 50 mg, sodium salicylate 800 mg, or saline 20 minutes before an inhaled MBS challenge." | 5.08 | Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5'-monophosphate challenge in asthma. ( Knox, A; Pavord, I; Tattersfield, A; Wang, M; Wisniewski, A, 1996) |
| "This study was designed to investigate the protective effect of cromolyn sodium on airway sensitivity to sulpyrine, and bronchial responsiveness to methacholine, and to investigate whether this protective activity is associated with reduction in aspirin-induced excretion of urinary leukotriene E4 (u-LTE4), a marker of the cysteinyl LT overproduction that participates in the pathogenesis of aspirin-induced asthma." | 5.08 | Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma. ( Akahori, K; Amayasu, H; Hasegawa, H; Nakabayashi, M; Nakagawa, H; Sakamoto, H; Sakamoto, M; Shoji, T; Tajimab, T; Yamawaki, Y; Yoshida, S, 1998) |
| "From bronchoprovocation studies and investigations of the acute effects of drugs that inhibit leukotrienes (LT), the hypothesis has emerged that leukotrienes are important mediators of airway obstruction and other symptoms in aspirin-intolerant asthma (AIA)." | 5.08 | Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. ( Bochenek, G; Boodhoo, TI; Dahlén, B; Dahlén, SE; Dubé, LM; Kumlin, M; Mastalerz, L; Nizankowska, E; Pinis, G; Swanson, LJ; Szczeklik, A; Wright, S; Zetterström, O, 1998) |
| " To investigate whether prostaglandin production could also modulate the bronchial antireactive activity of this diuretic drug, we investigated the effect of inhaled lysine acetylsalicylate (162 mg) and of furosemide (18 mg), alone and in combination, on the bronchial obstructive response to ultrasonically nebulized water in asthmatic patients." | 5.07 | Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate. ( Berni, F; Bianco, S; Pieroni, MG; Refini, RM; Robuschi, M; Sestini, P; Vaghi, A, 1993) |
| " The coexistence of CRS, bronchial asthma and aspirin intolerance (aspirin triad) is an adverse prognostic factor with higher risk of recurrences." | 3.91 | Analysis of the impact of bronchial asthma and hypersensitivity to aspirin on the clinical course of chronic sinusitis with nasal polyps. ( Dąbrowska, K; Fendler, W; Pagacz, K; Pietruszewska, W; Podwysocka, M, 2019) |
| "A considerable number of asthmatic patients with no history of aspirin intolerance responded to the inhalation aspirin challenge." | 3.76 | Airway responsiveness to inhaled aspirin is influenced by airway hyperresponsiveness in asthmatic patients. ( Choi, IS; Han, ER; Kim, CS; Kim, DE; Kim, S; Kim, YJ; Park, DJ, 2010) |
| "Aspirin induced asthma (AIA) is a syndrome characterised by intolerance to acetylsalycilic acid (ASA), nasal polyps and bronchial asthma, being the metabolic shift of arachidonic acid toward the lipoxygenase pathway and hyper-production of cysteinyl-leukotrienes (cys-LTs) the current pathogenetic hypothesis." | 3.74 | Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders. ( Dal Negro, RW; Micheletto, C; Tognella, S; Trevisan, F; Visconti, M, 2007) |
| " Aspirin-induced asthma tended to be severe." | 3.71 | Airway hyperresponsiveness and pulmonary function in adult asthma. ( Fukushima, C; Kawano, T; Kohno, S; Matsuse, H; Mitsuta, K; Obase, Y; Shimoda, T, 2001) |
| "Cysteinyl leukotrienes (cysLTs) are considered to be the most important mediator involved in the pathogenesis of aspirin-intolerant asthma (AIA)." | 3.70 | Effects of pranlukast, a cysteinyl leukotriene antagonist, on bronchial responsiveness to methacholine in aspirin-intolerant asthmatics treated with corticosteroids. ( Haruta, Y; Hiyama, K; Hozawa, S; Ishioka, S; Maeda, A; Tamagawa, K; Watanabe, T; Yamakido, M, 2000) |
| "Sensitivity to amalgam may cause exacerbation of aspirin-intolerant asthma in some patients." | 3.70 | Amalgam allergy associated with exacerbation of aspirin-intolerant asthma. ( Amayasu, H; Hasegawa, H; Ishizaki, Y; Mikami, H; Nakagawa, H; Onuma, K; Shoji, T; Yoshida, S, 1999) |
| "Inhalation of aerosolized lysine-aspirin (L-ASA) has been described as an alternative diagnostic method in aspirin-sensitive asthma." | 3.69 | Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. ( Park, HS, 1995) |
| "Methacholine provocation test, bronchial reversibility test, aspirin inhalation test, and cough provocation test have been performed at our institute to examine pathophysiology and to diagnose bronchial diseases." | 3.68 | [Bronchial provocation test in bronchial asthma]. ( Fujimura, M; Hashimoto, T; Kamio, Y, 1993) |
| " We assayed urinary LTE4 in 17 normal subjects, 31 subjects with asthma without aspirin sensitivity, and 10 aspirin-sensitive subjects." | 3.68 | Urinary leukotriene E4 in bronchial asthma. ( Christie, PE; Hawksworth, RJ; Lee, TH; Smith, CM; Thien, FC, 1992) |
| " Thirty patients suffered from polyps and bronchial hyperreactivity; 12 patients in this group also suffered from aspirin intolerance." | 3.68 | Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma. ( Goetz, R; Jankowski, R; Moneret-Vautrin, DA; Wayoff, M, 1992) |
| "The following bronchial provocation tests were carried out: 310 with acetylcholine, 216 with submaximal physical exercise, 246 with cold air inhalation, and 103 with aspirin in healthy subjects, relatives of bronchial asthma patients, in patients with preasthma and asthma in a stage of exacerbation abatement or remission." | 3.68 | [The results of the dynamic observation of bronchial hyperreactivity in risk-group subjects and in bronchial asthma patients. Some corrective procedures]. ( Didur, MD; Emel'ianov, AV; Evsiukova, EV; Nazarova, VA; Shchemelinina, TI; Sinitsina, TM, 1991) |
| " In aspirin asthma following aspirin bronchial provocation NCA increases in 50% to 100% of the studied patients." | 3.68 | [Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity]. ( Grzegorczyk, J; Grzelewska-Rzymowska, I; Rozniecki, J; Szmidt, M, 1991) |
| "The inhalation challenge with lysine-aspirin (L-ASA) using the dosimeter method allows the construction of a dose-response curve and the quantitative estimation of airway responsiveness to the drug." | 1.28 | Aspirin-induced asthma and bronchial hyperresponsiveness. ( Cocco, G; Masi, C; Melillo, E; Melillo, G; Padovano, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (60.61) | 18.2507 |
| 2000's | 11 (33.33) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Podwysocka, M | 1 |
| Dąbrowska, K | 1 |
| Fendler, W | 1 |
| Pagacz, K | 1 |
| Pietruszewska, W | 1 |
| Lee, TH | 4 |
| Woszczek, G | 1 |
| Farooque, SP | 1 |
| Kim, S | 1 |
| Choi, IS | 1 |
| Kim, YJ | 1 |
| Kim, CS | 1 |
| Han, ER | 1 |
| Park, DJ | 1 |
| Kim, DE | 1 |
| Levy, BD | 1 |
| De Sanctis, GT | 1 |
| Devchand, PR | 1 |
| Kim, E | 1 |
| Ackerman, K | 1 |
| Schmidt, B | 1 |
| Szczeklik, W | 1 |
| Drazen, JM | 1 |
| Serhan, CN | 1 |
| Riccioni, G | 1 |
| Della Vecchia, R | 1 |
| Menna, V | 1 |
| Lambo, MS | 1 |
| Di Ilio, C | 1 |
| D'Orazio, N | 1 |
| Bonfils, P | 1 |
| Avan, P | 1 |
| Micheletto, C | 1 |
| Visconti, M | 1 |
| Tognella, S | 1 |
| Trevisan, F | 1 |
| Dal Negro, RW | 1 |
| Nasser, SM | 1 |
| Park, HS | 1 |
| Bianco, S | 3 |
| Vaghi, A | 3 |
| Pieroni, MG | 3 |
| Robuschi, M | 3 |
| Refini, RM | 3 |
| Berni, F | 1 |
| Sestini, P | 3 |
| Fujimura, M | 1 |
| Kamio, Y | 1 |
| Hashimoto, T | 2 |
| Wang, M | 1 |
| Wisniewski, A | 1 |
| Pavord, I | 1 |
| Knox, A | 1 |
| Tattersfield, A | 1 |
| Matsuse, H | 2 |
| Shimoda, T | 2 |
| Matsuo, N | 1 |
| Fukushima, C | 2 |
| Takao, A | 1 |
| Sakai, H | 1 |
| Asai, S | 1 |
| Kohno, S | 2 |
| Dahlén, B | 1 |
| Nizankowska, E | 1 |
| Szczeklik, A | 1 |
| Zetterström, O | 1 |
| Bochenek, G | 1 |
| Kumlin, M | 1 |
| Mastalerz, L | 1 |
| Pinis, G | 1 |
| Swanson, LJ | 1 |
| Boodhoo, TI | 1 |
| Wright, S | 1 |
| Dubé, LM | 1 |
| Dahlén, SE | 1 |
| Yoshida, S | 5 |
| Nakagawa, H | 5 |
| Yamawaki, Y | 1 |
| Sakamoto, H | 3 |
| Akahori, K | 2 |
| Nakabayashi, M | 3 |
| Sakamoto, M | 1 |
| Hasegawa, H | 5 |
| Shoji, T | 5 |
| Tajimab, T | 1 |
| Amayasu, H | 5 |
| Mikami, H | 1 |
| Onuma, K | 2 |
| Ishizaki, Y | 3 |
| Hedman, J | 1 |
| Moilanen, E | 1 |
| Poussa, T | 1 |
| Nieminen, MM | 1 |
| Kawai, K | 1 |
| Shirai, T | 1 |
| Suzuki, K | 1 |
| Chida, K | 1 |
| Nakamura, H | 1 |
| Ishioka, S | 1 |
| Hozawa, S | 1 |
| Haruta, Y | 1 |
| Maeda, A | 1 |
| Tamagawa, K | 1 |
| Watanabe, T | 1 |
| Hiyama, K | 1 |
| Yamakido, M | 1 |
| Babu, KS | 1 |
| Salvi, SS | 1 |
| Mitsuta, K | 1 |
| Kawano, T | 1 |
| Obase, Y | 1 |
| Toyoda, Y | 1 |
| Matsukawa, H | 1 |
| Tsuriya, Y | 1 |
| Yanagihara, Y | 1 |
| Smith, CM | 1 |
| Hawksworth, RJ | 1 |
| Thien, FC | 1 |
| Christie, PE | 1 |
| Jankowski, R | 1 |
| Moneret-Vautrin, DA | 1 |
| Goetz, R | 1 |
| Wayoff, M | 1 |
| Arm, JP | 1 |
| Sinitsina, TM | 1 |
| Shchemelinina, TI | 1 |
| Didur, MD | 1 |
| Evsiukova, EV | 1 |
| Emel'ianov, AV | 1 |
| Nazarova, VA | 1 |
| Melillo, G | 1 |
| Padovano, A | 1 |
| Masi, C | 1 |
| Melillo, E | 1 |
| Cocco, G | 1 |
| Szmidt, M | 1 |
| Grzelewska-Rzymowska, I | 1 |
| Rozniecki, J | 1 |
| Grzegorczyk, J | 1 |
4 reviews available for aspirin and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Leukotriene E4: perspective on the forgotten mediator.
Topics: Animals; Aspirin; Asthma; Bronchial Hyperreactivity; Drug Hypersensitivity; Histamine; Humans; Leuko | 2009 |
Aspirin-induced early and late asthmatic response.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Hyperreactivity; Bronchoconstric | 1995 |
Aspirin and asthma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Aspirin; Asthma; Bronchial Hyperreactivi | 2000 |
The pathobiology of bronchial asthma.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Basement | 1992 |
9 trials available for aspirin and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ast | 1993 |
Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5'-monophosphate challenge in asthma.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adult; Anti-Inflammatory Agents, Non-Steroidal; | 1996 |
Protective effect of inhaled lysine acetylsalicylate on allergen-induced early and late asthmatic reactions.
Topics: Administration, Inhalation; Adolescent; Adult; Allergens; Anti-Inflammatory Agents, Non-Steroidal; A | 1997 |
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
Topics: Adrenergic beta-Agonists; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Hyperr | 1998 |
Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma.
Topics: Adult; Anti-Asthmatic Agents; Aspirin; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Test | 1998 |
Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses.
Topics: Administration, Inhalation; Adolescent; Adult; Allergens; Anti-Inflammatory Agents, Non-Steroidal; A | 1999 |
Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Blood Proteins; Bronchial Hyperreac | 1999 |
Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
Topics: Adult; Analgesics; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; | 2000 |
Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
Topics: Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Blood Protei | 2001 |
20 other studies available for aspirin and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Analysis of the impact of bronchial asthma and hypersensitivity to aspirin on the clinical course of chronic sinusitis with nasal polyps.
Topics: Adult; Aspirin; Asthma; Bronchial Hyperreactivity; Case-Control Studies; Drug Hypersensitivity; Fema | 2019 |
Airway responsiveness to inhaled aspirin is influenced by airway hyperresponsiveness in asthmatic patients.
Topics: Administration, Inhalation; Adolescent; Adult; Aspirin; Asthma; Asthma, Aspirin-Induced; Bronchial H | 2010 |
Lipoxins and aspirin-triggered lipoxins in airway responses.
Topics: Animals; Aspirin; Bronchi; Bronchial Hyperreactivity; Humans; Hydroxyeicosatetraenoic Acids; Inflamm | 2003 |
[Antileukotrienes in the therapy of bronchial asthma].
Topics: Adrenal Cortex Hormones; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Aspirin; Asthma; Asthma, E | 2003 |
Non-specific bronchial hyperresponsiveness is a risk factor for steroid insensitivity in nasal polyposis.
Topics: Administration, Oral; Aerosols; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2004 |
Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
Topics: Adult; Aspirin; Asthma; Bronchial Hyperreactivity; Cysteine; Female; Forced Expiratory Volume; Human | 2007 |
Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Hyperreactivity; Br | 1995 |
[Bronchial provocation test in bronchial asthma].
Topics: Aspirin; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cough; Humans; Methacholine | 1993 |
Aspirin-induced asthma as a risk factor for asthma mortality.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Hyperreactivity; Br | 1997 |
Amalgam allergy associated with exacerbation of aspirin-intolerant asthma.
Topics: Adult; Aspirin; Asthma; Bronchial Hyperreactivity; Dental Amalgam; Dipyrone; Female; Humans; Methach | 1999 |
Serum ECP and MPO, but not urinary LTE4, are associated with bronchial hyper-responsiveness.
Topics: Adult; Aged; Aspirin; Biomarkers; Blood Proteins; Bronchial Hyperreactivity; Bronchoconstrictor Agen | 1999 |
[Mild intermittent aspirin-induced asthma in a patient who became asymptomatic after removal of pet hamsters from home].
Topics: Adult; Allergens; Animals; Animals, Domestic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asth | 2000 |
Effects of pranlukast, a cysteinyl leukotriene antagonist, on bronchial responsiveness to methacholine in aspirin-intolerant asthmatics treated with corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aspirin; Asthma; Bronchial Hyperreactivity; Chromones; Drug To | 2000 |
Airway hyperresponsiveness and pulmonary function in adult asthma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Asthma; Bronchial Hyperreactivity; | 2001 |
[Effect of tazanolast on platelet activating factor-induced airway hyperresponsiveness in guinea pigs].
Topics: Animals; Aspirin; Bronchial Hyperreactivity; Guinea Pigs; Histamine Antagonists; Male; ortho-Aminobe | 1992 |
Urinary leukotriene E4 in bronchial asthma.
Topics: Adult; Aspirin; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Drug Hypersensitivit | 1992 |
Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma.
Topics: Aspirin; Asthma; Bronchial Hyperreactivity; Drug Hypersensitivity; Ethmoid Sinus; Female; Humans; In | 1992 |
[The results of the dynamic observation of bronchial hyperreactivity in risk-group subjects and in bronchial asthma patients. Some corrective procedures].
Topics: Acetylcholine; Aspirin; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cold Tempera | 1991 |
Aspirin-induced asthma and bronchial hyperresponsiveness.
Topics: Adolescent; Adult; Airway Resistance; Angioedema; Aspirin; Asthma; Bronchial Hyperreactivity; Bronch | 1991 |
[Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity].
Topics: Adult; Aspirin; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Chemotaxis, Leukocyt | 1991 |